Clinical Trial Update: Immune Reconstitution in Tuberculosis Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating immune reconstitution strategies in pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: Karolinska Institutet | Conditions: Pulmonary Tuberculosis (TB) | Phase 2 | Status: COMPLETED